Skip to main content
Clinical Trials/EUCTR2013-000381-11-NL
EUCTR2013-000381-11-NLActive, not recruitingPhase 1

Paracetamol or NSAID's in acute musculoskeletal syndromes - The PanAM Study

Academisch Medisch Centrum0 sitesStarted: May 17, 2013Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • - adult (18 years and older) patients
  • - presenting to the emergency department of the Academic Medical Centre (AMC) or to a general practice in Amsterdam South-East (Gezondheidscentrum Gein)
  • - with traumatic musculoskeletal complaints: isolated, non-penetrating injury of a limb, without a fracture
  • - within 48 hours
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 547
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 547

Exclusion Criteria

  • - previous treatment with analgesia for the same injury
  • - self inflicted injury (auto-mutilation”)
  • - presence of wound, joint dislocation, fracture or more then one injury
  • - daily use of paracetamol and/or NSAID’s and/or other analgesia within two weeks before presentation
  • - patients with chronic pain
  • - previous adverse reaction or known allergy to paracetamol, NSAID’s or omeprazol
  • - pregnancy
  • - previous gastro-intestinal hemorrhage or perforation after NSAID use
  • - active or recurrent peptic ulceration or peptic bleeding (2 or more evident episodes)
  • - previous exacerbation of asthma after use of NSAID’s or acetylsalicylic acid
  • - severe cardiac failure
  • - liver cirrhosis
  • - severe renal insufficiency (eGFR<30mL/min)
  • - bone marrow depression or blood dyscrasia (active or in past medical history)
  • - combined use of angiotensin converting enzyme inhibitors (or angiotensin receptor blockers) AND diuretics
  • - physical, visual or cognitive impairment or non-Dutch language speaking (unable to use NRS, pain diary or EQ5D questionnaire)

Investigators

Similar Trials